Diabetes mellitus
MONDO:0005015A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.
Also known as: DM, diabetes, diabetes mellitus, diabetes mellitus (disease)
3811 clinical trials for this condition and its sub-types, 1271 tagged with Diabetes mellitus itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Diabetes mellitus
-
Type 2 diabetes mellitus 2,286 trials
6 sub-types
-
Type 1 diabetes mellitus 815 trials · 816 incl. sub-types
1 sub-type
- Latent autoimmune diabetes in adults 12 trials
-
Gestational diabetes 226 trials
-
Monogenic diabetes 9 trials · 24 incl. sub-types
2 sub-types
- Maturity-onset diabetes of the young 8 trials · 13 incl. sub-types Sub-types →
- Neonatal diabetes mellitus 3 trials · 6 incl. sub-types Sub-types →
-
Cystic fibrosis-related diabetes 22 trials
-
Diabetic ketoacidosis 22 trials
-
Type 5 diabetes mellitus 1 trial
Most studied deeper sub-types
-
Could diabetes pills replace insulin shots in hospitals?
Disease control Stopped earlyThis study compares continuing oral diabetes medications (like metformin) versus switching to insulin in hospitalized adults with type 2 diabetes. About 255 participants will be randomly assigned to either stay on their usual pills or receive insulin injections. The goal is to se…
Phase 4 • Sponsor: Emory University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New shot aims to keep insulin flowing in type 1 diabetes
Disease control Stopped earlyThis study tests a drug called Diamyd in people aged 12 to 29 who were recently diagnosed with type 1 diabetes and have a specific genetic type (HLA DR3-DQ2). The goal is to see if Diamyd can help the body keep making its own insulin, which could improve blood sugar control and r…
Phase 3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Experimental diabetes drug trial halted early
Disease control Stopped earlyThis study tested an experimental drug called TOL-3021 in people with type 1 diabetes to see if it could help preserve the body's ability to produce insulin. The trial enrolled 78 participants aged 12 to 41 who had been diagnosed within the last 5 years. The study was terminated …
Phase 2 • Sponsor: Tolerion, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
CRISPR's diabetes cell therapy trial ends early
Disease control Stopped earlyThis early-stage study tested a new treatment called VCTX211 for people with type 1 diabetes. The goal was to see if implanting these special cells could help the body make insulin and reduce the need for insulin shots. Only 5 people took part, and the study was stopped early. Th…
Phase 1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Meals and exercise program aimed at managing diabetes in pregnancy
Disease control Stopped earlyThis study tested a community-based program called Meals 4 Moms for pregnant women with gestational diabetes. Participants received tailored meals, education, and activity monitoring. The goal was to see if the program was practical and acceptable. Only 8 women were enrolled befo…
Sponsor: UConn Health • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can cutting carbs and a diabetes drug help kidneys?
Disease control Stopped earlyThis small pilot study tested whether a low-carb diet (50-100 grams of carbs per day) combined with the diabetes drug dapagliflozin could improve blood sugar control in people with chronic kidney disease and prediabetes or type 2 diabetes. Four participants were split into two gr…
Sponsor: Department of Nephrology Clinic Ottakring Vienna • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Probiotic study for diabetes and COPD halted early
Disease control Stopped earlyThis study looked at whether taking probiotics alongside regular treatment could help lower blood sugar and improve lung function in people with both type 2 diabetes and chronic obstructive pulmonary disease (COPD). The trial planned to enroll 30 adults aged 50-85, but it was ter…
Sponsor: Glac Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Vitamin-Like supplement tested for diabetic nerve pain – but trial stopped early
Disease control Stopped earlyThis early-phase trial tested whether nicotinamide riboside (a form of vitamin B3 sold as Niagen) could help repair nerve damage in people with type 2 diabetes or prediabetes. Only 10 participants were enrolled before the study was terminated. The main goal was to measure changes…
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
AI reads eye photos to spot Diabetes-Related vision loss
Diagnosis Stopped earlyThis study tests whether an artificial intelligence program called NeoRetina can accurately detect diabetic retinopathy and diabetic macular edema from simple eye photographs. Researchers will compare the AI's analysis to standard exams by eye doctors. The goal is to see if this …
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Smartwatch aims to replace finger pricks and cuffs
Diagnosis Stopped earlyThis Mayo Clinic study tested a special smartwatch that uses light sensors to measure blood glucose, blood pressure, and heart signals. The goal was to see if the watch could give accurate readings compared to standard methods like finger-stick tests and blood pressure cuffs. The…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Diabetes education tailored for hispanic men shows promise in small study
Symptom relief Stopped earlyThis study tested whether a five-week culturally tailored diabetes education program could help Hispanic men aged 18-64 with type 2 diabetes improve their self-management behaviors like healthy eating, physical activity, and medication use. The program was designed specifically f…
Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a short daily workout help hospitalized diabetes patients?
Symptom relief Stopped earlyThis study tested whether hospitalized adults with type 2 diabetes or prediabetes could safely do 30 minutes of resistance training each day. The goal was to see if this exercise routine is feasible and if it helps control blood sugar and prevent muscle loss during a hospital sta…
Phase 1 • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New drug aimed at easing diabetic nerve pain hits roadblock
Symptom relief Stopped earlyThis study tested an experimental drug called GSK3858279 in 147 adults with chronic nerve pain from diabetes. The goal was to see if it could reduce pain better than a placebo. However, the trial was terminated early, so we have less information than planned.
Phase 2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
MRI might reveal hidden pancreatic risks in obesity
Knowledge-focused Stopped earlyThis study investigates whether MRI can detect early signs of pancreatic damage linked to obesity and metabolic syndrome, which are risk factors for pancreatic cancer. Researchers will compare MRI images with tissue samples from patients undergoing pancreatic surgery, as well as …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Tiny nerves may explain chronic cough in diabetes
Knowledge-focused Stopped earlyThis study looked at whether people with type 2 diabetes who have a chronic cough also have damage to small nerves in their skin. Researchers compared diabetic patients with and without chronic cough using nerve tests and skin biopsies. The study was terminated early with only 7 …
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Scientists probe hidden danger of low blood sugar in diabetes
Knowledge-focused Stopped earlyThis study looked at why people with type 1 diabetes often fail to sense dangerously low blood sugar (hypoglycemia). Researchers tested how opioid drugs like morphine and naloxone affect the body's ability to respond to low sugar. The goal was to better understand the problem, no…
Phase 2 • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Mental health study aims to uncover Long-Term heart risks
Knowledge-focused Stopped earlyThis study followed 167 adults with mental health issues like anxiety, depression, or sleep problems who visited their primary care doctor. Researchers used health conversations and a blood test to track lifestyle changes and heart disease risks over up to 20 years. The goal was …
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Hidden fat lumps may sabotage insulin: new study investigates
Knowledge-focused Stopped earlyThis study looked at whether small, hard-to-see fat lumps under the skin (called subclinical lipohypertrophy) change how insulin is absorbed in people with diabetes. Researchers planned to enroll 20 adults with type 1 or type 2 diabetes who use insulin and had these hidden lumps.…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Free diabetes classes for latinos aim to uncover health barriers
Knowledge-focused Stopped earlyThis study looked at Latino adults with diabetes who attended free education classes. Researchers collected information about their health habits, blood sugar levels, and barriers to medical care. The goal was to better understand the needs of this community, not to test a new tr…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Cystic fibrosis study aims to build a research database, not test a cure
Knowledge-focused Stopped earlyThis study is for people with cystic fibrosis and their family members. Its goal is to collect medical information and biological samples during regular clinic visits. These will be stored and used by researchers to learn more about how cystic fibrosis affects the body and how it…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Can a Stick-On sensor replace finger pricks before surgery?
Knowledge-focused Stopped earlyThis pilot study tested whether continuous glucose monitors (CGMs) could be used in the days before and after surgery to track blood sugar in people with diabetes. Researchers placed a CGM sensor on 22 patients during a preoperative visit and compared its readings to standard fin…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New E-Health system aims to keep tabs on chronic patients remotely
Knowledge-focused Stopped earlyThis pilot study tested an e-health system that uses tele-monitoring, tele-notification, and tele-coaching to help manage adults with at least two chronic conditions like heart failure, COPD, or diabetes. The goal was to see how well the system could detect health problems early.…
Sponsor: Air Liquide Santé International • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:48 UTC
-
Can two old drugs stop a dangerous diabetes complication?
Knowledge-focused Stopped earlyThis study tested whether two medications, naloxone (a nasal spray) and diazoxide (an oral pill), could prevent the body from losing its ability to sense low blood sugar—a condition called hypoglycemia unawareness. Only 4 healthy volunteers were enrolled before the trial was stop…
Phase 4 • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:35 UTC